Big day for vaccines? HUGE day for vaccines. https://www.reuters.com/business/healthcare-pharmaceuticals/moderna-merck-vaccine-combo-cut-melanoma-recurrence-by-44-study-2022-12-13/
Positive Moderna, Merck cancer vaccine data advances mRNA promise, shares rise
An experimental cancer vaccine from Moderna Inc <a href="https://www.reuters.com/companies/MRNA.O" target="_blank">(MRNA.O)</a> based on the messenger RNA (MRNA) technology used in successful COVID-19 vaccines has been shown to work against melanoma, sending Moderna shares more than 20% higher and driving up of other biotechs working on similar treatments.